Literature DB >> 17380268

Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.

Sam Maher1, Linda Feighery, David J Brayden, Siobhán McClean.   

Abstract

PURPOSE: Melittin has shown potential as a non-cytotoxic absorption enhancer in Caco-2 monolayers. Our objectives were to assess in vitro efficacy and cytotoxicity of melittin in two intestinal permeability models and investigate the potential mechanism by which melittin might enhance gastrointestinal absorption.
MATERIALS AND METHODS: The effects of melittin were examined in the mucus-secreting intestinal cell monolayers, HT29-MTX-E12 (E12), using transepithelial electrical resistance (TER), transmission electron microscopy (TEM) and the MTT viability assay. The effects of melittin on TER, permeability and short circuit current (Isc) were also investigated in rat colon mucosae mounted in Ussing chambers. Ion transporting capacity of tissue was measured in response to secretagogues as surrogate markers of cytotoxicity. Melittin stability was examined by a means of a hemolytic assay. The mechanism by which melittin decreases TER across the rat mucosa was examined with a range of enzymatic inhibitors.
RESULTS: Apical addition of melittin resulted in a reversible non-cytotoxic concentration-dependent decrease in TER across E12 monolayers, which was independent of the presence of mucus. Apical addition of melittin reduced TER and increased the permeability of [(14)C]-mannitol across rat colonic mucosae. The melittin-induced drop in TER in rat colon was significantly attenuated by W7 suggesting partial mediation by calmodulin.
CONCLUSIONS: The rapid and reversible nature of melittin's permeation enhancing properties and its limited cytotoxicity in polarized intestinal epithelia, suggests a potential drug delivery role for the peptide in oral formulations of poorly absorbed drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380268     DOI: 10.1007/s11095-007-9246-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  54 in total

Review 1.  Mode of action of membrane active antimicrobial peptides.

Authors:  Yechiel Shai
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

2.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Clostridium perfringens enterotoxin damages the human intestine in vitro.

Authors:  M E Fernández Miyakawa; V Pistone Creydt; F A Uzal; B A McClane; C Ibarra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.

Authors:  A Fasano; S Uzzau
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.

Authors:  A Fasano; B Baudry; D W Pumplin; S S Wasserman; B D Tall; J M Ketley; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

7.  Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase.

Authors:  T Y Ma; N T Hoa; D D Tran; V Bui; A Pedram; S Mills; M Merryfield
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

8.  Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II.

Authors:  T Borbiev; A D Verin; S Shi; F Liu; J G Garcia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-05       Impact factor: 5.464

9.  Increased tight junctional permeability is associated with the development of colon cancer.

Authors:  A P Soler; R D Miller; K V Laughlin; N Z Carp; D M Klurfeld; J M Mullin
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

10.  Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.

Authors:  T Lindmark; Y Kimura; P Artursson
Journal:  J Pharmacol Exp Ther       Date:  1998-01       Impact factor: 4.030

View more
  6 in total

Review 1.  Applications and evolution of melittin, the quintessential membrane active peptide.

Authors:  Shantanu Guha; Ryan P Ferrie; Jenisha Ghimire; Cristina R Ventura; Eric Wu; Leisheng Sun; Sarah Y Kim; Gregory R Wiedman; Kalina Hristova; Wimley C Wimley
Journal:  Biochem Pharmacol       Date:  2021-09-17       Impact factor: 6.100

2.  Effect of melittin on mice stomach.

Authors:  Osama Abu-Zinadah; Tarek Rahmy; Abeer Alahmari; Faiza Abdu
Journal:  Saudi J Biol Sci       Date:  2013-08-12       Impact factor: 4.219

3.  In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.

Authors:  Alyssa B Cox; Lee-Anne Rawlinson; Alan W Baird; Victoria Bzik; David J Brayden
Journal:  Pharm Res       Date:  2007-06-02       Impact factor: 4.200

4.  Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.

Authors:  Sam Maher; Linda Feighery; David J Brayden; Siobhán McClean
Journal:  Pharm Res       Date:  2007-03-21       Impact factor: 4.580

5.  Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Paul J Fawcett; Svetlana Golocorbin-Kon; Ivan Mikov; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jan-Mar       Impact factor: 2.569

6.  Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.

Authors:  Dallin Hubbard; Hamidreza Ghandehari; David J Brayden
Journal:  Biomacromolecules       Date:  2014-07-03       Impact factor: 6.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.